Product Description
Abstract
This case series takes from Merck and Johnson & Johnson’s Centocor unit conflict over distribution rights for two arthritis drugs, Remicade and Simponi. This case series allows students to negotiate their own agreement heading into arbitration with specific instructions for both business and legal teams from each organization.
Learning Objectives
The case series allows participants to apply core concepts such as BATNA, reservation price, and ZOPA, while also requiring them to consider more complex and challenging issues, such as uncertainty surrounding possible arbitration and multiple possible deal structures.
Subjects Covered
Mergers, Acquisitions, Government Regulation, Business Planning
Setting
Geographic: Global
Industry: Pharmaceutical
Event Year Begin: 2009
Hard Copy
For hard copies, please contact the HLS Case Studies Program at hlscasestudies@law.harvard.edu or +1-617-496-1316. When ordering, please let us know how many copies of confidential materials that you will need.
Accessibility
To obtain accessible versions of our products for use by those with disabilities, please contact the HLS Case Studies Program at hlscasestudies@law.harvard.edu or +1-617-496-1316.
Educator Materials
Watermarked educator copies of this product are available free of charge to educators and staff of degree-granting institutions. Please create an account or sign in as a registered educator to gain access to these materials.
Note: It can take up to three business days after you create an account to verify educator access. Verification will be confirmed via email.
Copyright Information
Please note that each purchase of this product entitles the purchaser to one download and use. If you need multiple copies, please purchase the number of copies you need. For more information, see Copying Your Case Study.
